The PEI (Paul-Ehrlich-Institut) does a comparative
Post# of 11802
(Total Views: 457)
Posted On: 05/07/2021 2:22:48 PM
The PEI (Paul-Ehrlich-Institut) does a comparative study on the sensitivity for the antigen tests which have been listed by BfArM. The goal of their study is to confirm the sensitivity of the device. "Sensitivity is an indicator of how many of the infected persons are recognized correctly by the rapid antigen test", i.e., they test against known infected samples only. GenViro's sensitivity is listed as 86.8%. I believe the minimum requirement for sensitivity is 80%.
PEI does NOT examine the specificity of the tests. "The specificity shows how successful the test is in identifying only those persons who are in fact positive. A 95 percent specificity would mean that out of 100 non infected persons, 95 percent are tested correctly as negative and five persons as false positive."
PEI does NOT examine the specificity of the tests. "The specificity shows how successful the test is in identifying only those persons who are in fact positive. A 95 percent specificity would mean that out of 100 non infected persons, 95 percent are tested correctly as negative and five persons as false positive."
Quote:
The tests which have been evaluated by the Paul-Ehrlich-Institut and fulfill the required criteria are marked appropriately on the list of the BfArM. Tests which do not fulfil the critera are removed from the list of the BfArM. Those tests marked with “No” in the list, have not yet been validated.
(2)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼